
Dartmet-PG1 Tablet ER
Marketer
Addii Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dartmet-PG1 Tablet ER
Glycemia-Control ER tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen. Take with food to prevent gastric distress. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double a dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals may cause hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before starting treatment. Pregnant or lactating individuals should seek medical advice prior to use. Kidney function will be assessed before initiating therapy. Limit alcohol consumption as it may exacerbate side effects.
Uses of Dartmet-PG1 Tablet ER
Managing Type 2 Diabetes
Major Benefits of Dartmet-PG1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. Dartmet-PG1 Extended-Release Tablet should be administered with a meal.
Common Side effects of Dartmet-PG1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dartmet-PG1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Dartmet-PG1 Extended-Release Tablets should be administered with a meal.
How Dartmet-PG1 Tablet ER works:
Dartmet-PG1 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dartmet-PG1 Tablet ER and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Dartmet-PG1 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dartmet-PG1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when prescribing Dartmet-PG1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Dartmet-PG1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Dartmet-PG1 Tablet ER. Dosage modification of Dartmet-PG1 Tablet ER might be necessary. Physician consultation is advised. Dartmet-PG1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Dartmet-PG1 Tablet ER :
Should you forget a Dartmet-PG1 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dartmet-PG1 Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
